1,576
Views
34
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Feeling too hot or cold after breast cancer: Is it just a nuisance or a potentially important prognostic factor?

, & , PhD
Pages 662-680 | Received 17 Feb 2010, Accepted 06 Jul 2010, Published online: 17 Sep 2010

References

  • Carpenter J, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nursing Forum 2002; 29(3)E16–E25
  • Mortimer J, Flatt S, Parker B, Gold E, Wasserman L, Natarajan L, Pierce J. Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat 2008; 108(3)421–426
  • Cuzick J, Sestak I, Cella D, Fallowfield L. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial. Lancet Oncol 2008; 9(12)1143–1148
  • Szmuilowicz ED. Menopausal vasomotor symptoms: Symptom or signal? Endocrine Today. 29 February 2009.
  • Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297(13)1465–1477
  • Gast GCM, Grobbee DE, Pop VJM, Keyzer JJ, Wijnands-van Gent CJM, Samsioe GN, Nilsson PM, van der Schouw YT. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51(6)1492–1498
  • Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994; 9(6)372–382
  • Stearns V, Hayes D. Approach to menopausal symptoms in women with breast cancer. Curr Treat Options Oncol 2002; 3(2)179–190
  • Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner C, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: A randomised phase 3 multicentre study. Lancet Oncol 2010; 11(6)561–570
  • Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, Craciunescu O, Stauffer P, Liotcheva V, Betof A, et al. A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. Int J Hyperthermia 2010; 26(5)514–521
  • Peer A, Grimm M, Zynda E, Repasky E. Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia. Immunol Res 2010; 46(1)137–154
  • Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Current opinion in investigational drugs. 2009; 10(6)550–558
  • Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23(13)3079–3085
  • Campbell NA. Biology. Benjamin/Cummings series in the life sciences. Benjamin/Cummings, Menlo Park, CA 1993
  • Mackowiak PA. Concepts of fever. Arch Int Med 1998; 158(17)1870–1881
  • Cabanac M. Temperature regulation. Ann Rev Phys 1975; 37(1)415–439
  • Johnson RH. The autonomic nervous system and body temperature. Proc Royal Soc Med 1966; 59(5)463–466
  • Gordon CJ. Temperature regulation in laboratory rodents. Cambridge University Press, Cambridge 1993
  • Frisancho AR. Human adaptation and accommodation. University of Michigan Press, Michigan 1995
  • Guyton AC, Hall JE. Textbook of Medical Physiology11th. Saunders, Philadelphia 2006
  • Lu SH, Dai YT. Normal body temperature and the effects of age, sex, ambient temperature and body mass index on normal oral temperature: A prospective, comparative study. Int J Nurs Stud 2009; 46(5)661–668
  • Brobeck JR. Food intake as a mechanism of temperature regulation. Yale J Bio Med 1948; 20(6)545–552
  • Rhind SG, Gannon GA, Shephard RJ, Buguet A, Shek PN, Radomski MW. Cytokine induction during exertional hyperthermia is abolished by core temperature clamping: Neuroendocrine regulatory mechanisms. Int J Hyperthermia 2004; 20(5)503–516
  • Mostardi R, Kubica R, Veicsteinas A, Margaria R. The effect of increased body temperature due to exercise on the heart rate and on the maximal aerobic power. Eur J Applied Physiol 1974; 33(3)237–245
  • Satinoff E. Neural organization and evolution of thermal regulation in mammals. Science. 1978; 201(4350)16–22
  • Charkoudian N. Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clin Proc 2003; 78(5)603–612
  • Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000; 31: S157–S161
  • Cameron JR, Skofronick JG, Grant RM. Physics of the body (Medical Physics Series)2nd. Medical Physics Publishing, Madison 1999
  • Frank SM, Raja SN, Bulcao CF, Goldstein DS. Relative contribution of core and cutaneous temperatures to thermal comfort and autonomic responses in humans. J Appl Physiol 1999; 86(5)1588–1593
  • Bennett AF. Evolution of the control of body temperature: Is warmer better?. Comparative Physiology: Life in Water and on Land, P Dejours, CR Taylor, ER Weibel. Litvia Press, Padova 1987; 421–431
  • Landsberg L, Young JB, Leonard WR, Linsenmeier RA, Turek FW. Is obesity associated with lower body temperatures? Core temperature: A forgotten variable in energy balance. Metabolism 2009; 58(6)871–876
  • Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444(7121)847–853
  • Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest 1986; 78(6)1568–1578
  • Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322(21)1477–1482
  • Spiegelman B. Obesity and the regulation of energy balance. Cell 2001; 104(4)531–543
  • Landsberg L, Saville ME, Young JB. Sympathoadrenal system and regulation of thermogenesis. Am J Physiol Endocrin Metab 1984; 247(2)E181–189
  • Doucet E, St Pierre S, Almras N, Desprs JP, Bouchard C, Tremblay A. Evidence for the existence of adaptive thermogenesis during weight loss. Br J Nutr 2001; 85: 715–723
  • Doucet E, Imbeault P, St-Pierre S, Alméras N, Mauriège P, Després JPP, Bouchard C, Tremblay A. Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men. Clin Sci 2003; 105(1)89–95
  • Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332(10)621–628
  • Woods SC, Seeley RJ, Porte D, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280(5368)1378–1383
  • O’Connor A. Really? - Is it true that body temperature declines with age? New York Times 28 December 2009.
  • Castle SC, Norman DC, Yeh M, Miller D, Yoshikawa TT. Fever response in elderly nursing home residents: Are the older truly colder?. J Am Geriatr Soc 1991; 39(9)853–857
  • Günes UYY, Zaybak A. Does the body temperature change in older people?. J Clin Nurs 2008; 17(17)2284–2287
  • Salvosa CB, Payne PR, Wheeler EF. Environmental conditions and body temperatures of elderly women living alone or in local authority home. Br Med J 1971; 4(5788)656–659
  • Fox RH, Woodward PM, Exton-Smith AN, Green MF, Donnison DV, Wicks MH. Body temperatures in the elderly: A national study of physiological, social, and environmental conditions. Br Med J 1973; 1(5847)200–206
  • Kenney WL, Munce TA. Invited review: Aging and human temperature regulation. J Appl Physiol 2003; 95(6)2598–2603
  • Collins KJ, Dore C, Exton-Smith AN, Fox RH, MacDonald IC, Woodward PM. Accidental hypothermia and impaired temperature homoeostasis in the elderly. Br Med J 1977; 1(6057)353–356
  • Horvath SM, Rochelle RD. Hypothermia in the aged. Environ Health Perspect 1977; 20: 127–130
  • Kenney WL, Armstrong CG. Reflex peripheral vasoconstriction is diminished in older men. J Appl Physiol 1996; 80(2)512–515
  • Falk B, Bar-Or O, Smolander J, Frost G. Response to rest and exercise in the cold: Effects of age and aerobic fitness. J Appl Physiol 1994; 76(1)72–78
  • Drinkwater BL, Bedi JF, Loucks AB, Roche S, Horvath SM. Sweating sensitivity and capacity of women in relation to age. J Appl Physiol 1982; 53(3)671–676
  • Shoenfeld Y, Udassin R, Shapiro Y, Ohri A, Sohar E. Age and sex difference in response to short exposure to extreme dry heat. J Appl Physiol 1978; 44(1)1–4
  • Krems C, Lührmann PM, Strassburg A, Hartmann B, Neuhäuser-Berthold M. Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. Eur J Clin Nutr 2005; 59(2)255–262
  • Poehlman ET, Arciero PJ, Goran MI. Endurance exercise in aging humans: Effects on energy metabolism. Exerc Sport Science Rev 1994; 22: 251–284
  • Danforth E, Burger A. The role of thyroid hormones in the control of energy expenditure. Clin Endocrin Metab 1984; 13(3)581–595
  • Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O’Higgins NJ. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab 1996; 81(3)937–941
  • Kronenberg F. Hot flashes: Phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994; 29(3–4)319–336
  • Carpenter JS, Wells N, Lambert B, Watson P, Slayton T, Chak B, Hepworth JT, Worthington WB. A pilot study of magnetic therapy for hot flashes after breast cancer. Cancer Nurs 2002; 25(2)104–109
  • Kouriefs C, Georgiou M, Ravi R. Hot flashes and prostate cancer: Pathogenesis and treatment. Br J Urology Intl 2002; 89(4)379–383
  • Freedman R. Hot flashes: Behavioral treatments, mechanisms, and relation to sleep. Am J Med 2005; 118(12)124–130
  • Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80(8)2354–2358
  • Carpenter JS, Gautam S, Freedman RR, Andrykowski M. Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors. Menopause 2001; 8(3)181–188
  • Carpenter JS, Gilchrist JM, Chen K, Gautam S, Freedman RR. Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause 2004; 11(4)375–381
  • Brück K. Adaptive changes in thermoregulation and their neuropharmacological basis. Pharmacol Ther 1987; 35(1–2)163–215
  • Mekjavic IB, Sundberg CJ, Linnarsson D. Core temperature ‘null zone’. J Appl Physiol 1991; 71(4)1289–1295
  • Freedman R, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999; 181(1)66–70
  • Loprinzi CL, Michalak JC, Quella SK, O’Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, et al. Megestrol Acetate for the Prevention of Hot Flashes. N Engl J Med 1994; 331(6)347–352
  • Brooks EM, Morgan AL, Pierzga JM, Wladkowski SL, O’Gorman JT, Derr JA, Kenney WL. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997; 83(2)477–484
  • Tankersley CG, Nicholas WC, Deaver DR, Mikita D, Kenney WL. Estrogen replacement in middle-aged women: Thermoregulatory responses to exercise in the heat. J Appl Physiol 1992; 73(4)1238–1245
  • Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L. Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis. JAMA 2006; 295(17)2057–2071
  • Charkoudian N, Johnson JM. Female reproductive hormones and thermoregulatory control of skin blood flow. Exerc Sport Science Rev 2000; 28(3)108–112
  • Greendale G. Symptom relief and side effects of postmenopausal hormones: Results from the postmenopausal estrogen/progestin interventions trial. Obstet Gynecol 1998; 92(6)982–988
  • Hutton JD, Jacobs HS, Murray MA, James VH. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1978; 1(8066)678–681
  • Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril 2000; 74(1)20–23
  • Freedman R. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004; 82(1)138–144
  • Aksel S, Schomberg DW, Tyrey L, Hammond CB. Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. Am J Obstet Gynecol 1976; 126(2)165–169
  • Stone SC, Mickal A, Rye PH. Postmenopausal symptomatology, maturation index, and plasma estrogen levels. Obstet Gynecol 1975; 45(6)625–627
  • Younus J, Kligman L. Management of aromatase inhibitor-induced arthralgia. Curr Oncol 2010; 17: 87–90
  • Carpenter JS. Hot flashes and their management in breast cancer. Semin Oncol Nurs 2000; 16(3)214–225
  • Carpenter JS, Andrykowski MA, Cordova M, Cunningham L, Studts J, McGrath P, Kenady D, Sloan D, Munn R. Hot flashes in postmenopausal women treated for breast carcinoma: Prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998; 82(9)1682–1691
  • Harris P. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symp Man 2002; 23(6)501–509
  • LeBlanc ES, Neiss MB, Carello PE, Samuels MH, Janowsky JS. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 2007; 14(2)191–202
  • Love RR. Tamoxifen therapy in primary breast cancer: Biology, efficacy, and side effects. J Clin Oncol 1989; 7(6)803–815
  • Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Int Med 1991; 151(9)1842–1847
  • Pasacreta JV, McCorkle R. Providing accurate information to women about tamoxifen therapy for breast cancer: Current indications, effects, and controversies. Oncol Nurs Forum 1998; 25(9)1577–1583
  • Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson W, Kelaghan J, Christensen BB. Mayo Clinic and North Central Cancer Treatment Group hot flash studies. Menopause 2008; 15(4)655–660
  • Reichman BS, Green KB. Breast cancer in young women: Effect of chemotherapy on ovarian function, fertility, and birth defects. J Nat Cancer Inst 1994; 16: 125–129
  • Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Tsuchiya N, Yuzurihara M, et al. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006; 91(12)4805–4808
  • Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang R. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004; 109(4)507–515
  • Mormont MC, Lévi F. Circadian-system alterations during cancer processes: A review. Int J Cancer 1997; 70(2)241–247
  • Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review. JAMA 2004; 291(13)1610–1620
  • Kontos M, Agbaje OF, Rymer J, Fentiman IS. What can be done about hot flashes after treatment for breast cancer?. Climacteric 2010; 13(1)4–21
  • Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008; 19(10)1669–1680
  • Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clin Therapeutics 2007; 29(2)230–241
  • Gordon PR, Kerwin JP, Boesen KGG, Senf J. Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population. Menopause 2006; 13(4)568–575
  • Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, et al. Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. J Clin Oncol 2005; 23(28)6919–6930
  • Kimmick GG, Lovato J, McQuellon R, Robinson E, Muss HB. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 2006; 12(2)114–122
  • Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 2003; 289(21)2827–2834
  • Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20(6)1578–1583
  • Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 1998; 7(2)129–132
  • Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, van Breemen RB, Lankin DC, Pauli GF, et al. In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent. J Agric Food Chem 2008; 56(24)11718–11726
  • Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19(10)2739–2745
  • Loprinzi C, Kugler J, Sloan J, Mailliard J, Lavasseur B, Barton D, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 2000; 356(9247)2059–2063
  • Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, Johnsona CS, Sheltonb RC. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 2007; 12(1)124–135
  • Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD, Mailliard JA, Tschetter LK, Fitch TR, et al. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 2006; 24(9)1409–1414
  • Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, Pierce HI, Dragalin V, Morrow GB. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study. Ann Intern Med 2000; 132(10)788–793
  • Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: Results from a community-based prospective study. Am J Epidemiol 2001; 153(8)790–793
  • Scambia G, Mango D, Signorile PG, Angeli RA, Palena C, Gallo D, Bombardelli E, Morazzoni P, Riva A, Mancuso S. Clinical effects of a standardized soy extract in postmenopausal women. Menopause 2000; 7(2)105–111
  • Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flashes: A multicenter, double-blind, randomized, placebo-controlled study. Menopause 2002; 9(5)329–334
  • Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, Wattie A, Prior JC. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: A randomized, controlled clinical trial. J Clin Oncol 2002; 20(6)1449–1455
  • Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol 2000; 18(5)1068+
  • Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: The isoflavone clover extract (ICE) study: A randomized controlled trial. JAMA 2003; 290(2)207–214
  • Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997; 337(5)295–300
  • Quella S, Loprinzi C, Sloan J, Vaught N, Dekrey W, Fischer T, Finck G, Pierson N, Pisansky T. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. J Urology 1999; 161(1)360
  • Kavanagh JJ, Roberts W, Townsend P, Hewitt S. Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer. J Clin Oncol 1989; 7(1)115–118
  • Miller DS, Brady MF, Barrett RJ. A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol 1992; 15(2)125–128
  • Tresukosol D, Kudelka AP, Edwards CL, Silva EG, Kanojia M, Kavanagh JJ. Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report. J Reproductive Med. 1996; 41(5)363–366
  • Hidden costs of breast cancer 2005. Available from: http://www.countrydoctor.co.uk/precis/precis%20-%20Breast%20cancer%20costs.htm (accessed 1 July 2010)
  • Clark W. Factor analysis validates the cluster structure of the dendrogram underlying the Multidimensional Affect and Pain Survey (MAPS) and challenges the a priori classification of the descriptors in the McGill Pain Questionnaire (MPQ). Pain 2003; 106(3)357–363
  • Olson K. A new way of thinking about fatigue: A reconceptualization. Oncol Nurs Forum 2007; 34(1)93–99
  • McDaniel RW, Rhodes VA. Development of a preparatory sensory information videotape for women receiving chemotherapy for breast cancer. Cancer Nurs 1998; 21(2)143–148
  • Rudberg L, Carlsson M, Nilsson S, Wikblad K. Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nurs 2002; 25(3)187–195
  • Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: Emerging role in cancer. Nat Rev Cancer 2003; 3(2)110–116
  • Wülfing P, Diallo R, Kersting C, Wülfing C, Poremba C, Rody A, Greb RR, Böcker W, Kiesel L. Expression of endothelin-1, endothelin-a, and endothelin-b receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 2003; 9(11)4125–4131
  • Hans G, Deseure K, Robert D, De Hert S. Neurosensory changes in a human model of endothelin-1 induced pain: A behavioral study. Neurosci Lett 2007; 418(2)117–121
  • Leon LR. Hypothermia in systemic inflammation: Role of cytokines. Frontiers in Bioscience 2004; 9: 1877–1888
  • Gavrilova O, Leon LR, Marcus-Samuels B, Mason MM, Castle AL, Refetoff S, Vinson C, Reitman ML. Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc Natl Acad Sci 1999; 96(25)14623–14628
  • Buchanan TA, Cane P, Eng CC, Sipos GF, Lee C. Hypothermia is critical for survival during prolonged insulin-induced hypoglycemia in rats. Metabolism 1991; 40(3)330–334
  • Graf R, Krishna S, Heller HC. Regulated nocturnal hypothermia induced in pigeons by food deprivation. Am J Physiol 1989; 256(3)R733–738
  • Malvin GM, Wood SC. Behavioral hypothermia and survival of hypoxic protozoans Paramecium caudatum. Science 1992; 255(5050)1423–1425
  • Rausch RN, Crawshaw LI, Wallace HL. Effects of hypoxia, anoxia, and endogenous ethanol on thermoregulation in goldfish, Carassius auratus. Am J Phys 2000; 278(3)R545–R555
  • Ibuka N, Fukumura K. Unpredictable deprivation of water increases the probability of torpor in the Syrian hamster. Physiol Behav 1997; 62(3)551–556
  • Romanovsky A, Szekely M. Fever and hypothermia: Two adaptive thermoregulatory responses to systemic inflammation. Med Hypotheses 1998; 50(3)219–226
  • Klein MS, Conn CA, Kluger MJ. Behavioral thermoregulation in mice inoculated with influenza virus. Physiol Behav 1992; 52(6)1133–1139
  • Lagerspetz KY, Väätäinen T. Bacterial endotoxin and infection cause behavioural hypothermia in infant mice. Comp Biochem Phys 1987; 88(3)519–521
  • Muller CB, Schmid-Hempel P. Exploitation of cold temperature as defence against parasitoids in bumblebees. Nature 1993; 363(6424)65–67
  • Gordon CJ, Stead AG. Effect of nickel and cadmium chloride on autonomic and behavioral thermoregulation in mice. Neurotoxicology 1986; 7(3)97–106
  • Goldberg RM, Loprinzi CL, O’Fallon JR, Veeder MH, Miser AW, Mailliard JA, Michalak JC, Dose AM, Rowland KM, Jr, Burnham NL. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994; 12(1)155–158
  • Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, Novotny PJ, Rummans TA, Dumesic DA, Perez EA. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998; 16(7)2377–2381
  • Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998; 16(2)495–500
  • Bessell EM, Selby C, Ellis IO. Severe hypoglycaemia caused by raised insulin-like growth factor II in disseminated breast cancer. J Clin Path 1999; 52(10)780–781
  • Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000; 11(1)17–22
  • Bertelli G, Venturini M, Del Mastro L, Bergaglio M, Sismondi P, Biglia N, Venturini S, Porcile G, Pronzato P, Costantini M. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: A randomized study. Ann Oncol 2002; 13(6)883–888
  • Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002; 23(4)337–345
  • Carpenter J, Elam J, Ridner S, Carney P, Cherry G, Cucullu H. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nursing Forum 2004; 31(3)591–598
  • Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97(1)30–39
  • Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 2005; 23(36)9312–9318
  • Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ. Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet 2005; 366(9488)818–824
  • Loibl S, Schwedler K, von Minckwitz G, Strohmeier R, Mehta KM, Kaufmann M. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients–A double-blind, randomized study. Ann Oncol 2007; 18(4)689–693
  • Elkins G, Marcus J, Stearns V, Hasan Rajab M. Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors. Psychooncology 2007; 16(5)487–492
  • Deng G, Vickers AJ, Yeung KS, D’Andrea GM, Xiao H, Heerdt AS, Sugarman S, Troso-Sandoval T, Seidman AD, Hudis CA, et al. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 2007; 25(35)5584–5590
  • Pierce JP, Natarajan L, Caan BJ, Flatt SW, Kealey S, Gold EB, Hajek RA, Newman VA, Rock CL, Pu M, et al. Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: Subgroup analysis of the Women's Healthy Eating and Living Study. Am J Clin Nutr 2009; 89(5)1565 S–1571
  • Quella S, Loprinzi C, Sloan J, Novotny P, Perez E, Burch P, Antolak SJ, Pisansky TM. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urology 1999; 162(1)98–102
  • Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 2004; 31(2)202–212
  • Badawy YA, Bayoumi DM. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events. J Egypt Public Health Assoc 1992; 67(5–6)579–591
  • Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12(9)2759–2766
  • Konsman J. Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 2002; 25(3)154–159
  • Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999; 19(2B)1427–1432
  • Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003; 88(11)1721–1726
  • DeMichele A, Martin AMM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B. Interleukin-6 -174G–>C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 2003; 63(22)8051–8056
  • Meeske K, Smith A, Alfano C, McGregor B, McTiernan A, Baumgartner K, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L. Fatigue in breast cancer survivors two to five years post diagnosis: A HEAL study report. Qual Life Res 2007; 16(6)947–960
  • Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89(5)2119–2126
  • Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64(4)604–611
  • Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. Br Med J 2005; 330(7493)702–706
  • Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18(4)743–753
  • Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92(S6)1684–1688
  • Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol 2006; 169(5)1505–1522
  • Giovannucci E. Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 2001; 131(11)3109 S–3120
  • Ibrahim Y, Yee D. Insulin-like growth factor-I and cancer risk. Growth Hormone IGF Res 2004; 14(4)261–269
  • Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obesity Res 2004; 12(2)180–186
  • Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266(1)37–56
  • Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003; 46(11)1483–1488
  • Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 2002; 21(6)1285–1292
  • Somasundar P, McFadden DW, Hileman SM, Vona-Davis L. Leptin is a growth factor in cancer. J Surg Res 2004; 116(2)337–349
  • Glossary of terms for thermal physiology. Eur J Physiol 1987;410(4):567–587
  • Gordon CJ. Temperature and toxicology: An integrative, comparative, and environmental approach. Taylor & Francis, Boca Raton 2005; 169–171
  • Netea MG, Kullberg BJ, Van der Meer JWM. Circulating cytokines as mediators of fever. Clin Infect Dis 2000; 31: S178–S184
  • Schmitt BD. Fever in childhood. Pediatrics 1984; 74(5)929–936
  • Stern RC. Pathophysiologic basis for symptomatic treatment of fever. Pediatrics 1977; 59(1)92–98
  • Romanovsky AA, Almeida MC, Aronoff DM, Ivanov AI, Konsman JP, Steiner AA, Turek VF. Fever and hypothermia in systemic inflammation: Recent discoveries and revisions. Frontiers Biosci 2005; 10: 2193–2216
  • Steiner AA, Hunter JC, Phipps SM, Nucci TB, Oliveira DL, Roberts JL, Scheck AC, Simmons DL, Romanovsky AA. Cyclooxygenase-1 or -2–Which one mediates lipopolysaccharide-induced hypothermia?. Am J Physiol Regul Integr Comp Physiol 2009; 297(2)R485–494
  • Kageyama R, Ohkubo H, Nakanishi S. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem Biophys Res Com 1985; 129(3)826–832
  • Blanque R, Meakin C, Millet S, Gardner C. Hypothermia as an indicator of the acute effects of lipopolysaccharides: Comparison with serum levels of IL1ÃŽÂ2, IL6 and TNFα. Gen Pharmacol: Vasc Sys 1996; 27(6)973–977
  • Romanovsky AA, Shido O, Sakurada S, Sugimoto N, Nagasaka T. Endotoxin shock: Thermoregulatory mechanisms. Am J Physiol Regul Integr Comp Physiol 1996; 270(4)R693–703
  • Almeida MC, Steiner AA, Branco LGS, Romanovsky AA. Cold-seeking behavior as a thermoregulatory strategy in systemic inflammation. Eur J Neursci 2006; 23(12)3359–3367
  • Steiner AA, Romanovsky AA. Leptin: At the crossroads of energy balance and systemic inflammation. Prog Lipid Res 2007; 46(2)89–107
  • Straub RH, Cutolo M, Buttgereit F, Pongratz G. Energy regulation and neuroendocrine immune control in chronic inflammatory diseases. J Int Med 2010; 267(6)543–560
  • Kluger MJ. Fever: Role of pyrogens and cryogens. Physiol Rev 1991; 71(1)93–127
  • Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008; 24(1)41–56
  • Bull JM, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM. Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: A description of a phase I-II protocol. Int J Hyperthermia 2008; 24(8)649–662
  • Ostberg JR, Taylor SL, Baumann H, Repasky EA. Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J Leukoc Biol 2000; 68(6)815–820
  • Ostberg JR, Patel R, Repasky EA. Regulation of immune activity by mild (fever-range) whole body hyperthermia: Effects on epidermal Langerhans cells. Cell Stress Chaperones 2000; 5(5)458–461
  • Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007; 82(5)1322–1331
  • Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177(1)137–147
  • Park HG, Han SI, Oh SY, Kang HS. Cellular responses to mild heat stress. Cell Mol Life Sciences 2005; 62(1)10–23
  • Chen Q, Wang WC, Bruce R, Li H, Schleider DM, Mulbury MJ, Wallace PK, Baumann H, Evans SS. Central role of il-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity 2004; 20(1)59–70
  • Evans SS, Fisher DT, Skitzki JJ, Chen Q. Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress. Int J Hyperthermia 2008; 24(1)67–78
  • Blazícková S, Rovenský J, Koska J, Vigas M. Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharm Res 2000; 20(1–2)41–46

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.